Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Carrollton › NPI 1578898920
Physician

Muhammad Ali Mirza, MD, P.A.

Muhammad Ali Mirza, MD, P.A. was paid $3.86M by Medicaid between Jan 2018 and Dec 2024, across 55 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 17% of everything it billed.

33Billing provider infoMUHAMMAD ALI MIRZA, MD, P.A.
CARROLLTON, TX 75010
33aNPI1578898920assigned 10/02/2009
33bProvider typePediatrics Physician
28Total paid$3.86M
24GClaims179,330
24DCodes billed55
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pediatrics Physician providers in Texas

Rank by total paid#115 of 1,136
Median peer was paid$329K
This provider vs. median12×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018586$9K
2019579$10K
20209,203$164K
202141,282$856K
202247,228$978K
202342,530$973K
2024incomplete37,922$871K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 17% 17,756 16,379 $644K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 14% 7,175 7,039 $547K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 13% 6,410 6,299 $519K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 10% 7,799 7,382 $403K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 9.8% 4,393 4,323 $380K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 9.7% 5,047 4,885 $374K
90460 Immunization administration through 18 years of age via any route, first or only component 9.5% 35,113 14,329 $365K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2.5% 3,946 3,872 $96K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 2.2% 2,189 2,120 $86K
99381 1.8% 881 861 $70K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1.7% 4,799 4,597 $65K
96110 Developmental screening, with scoring and documentation, per standardized instrument 1.6% 7,712 5,496 $62K
43 more codes
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.3% 3,625 $49K
90461 <1% 8,649 $38K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,842 $30K
99383 <1% 287 $26K
G8510 Screening for depression is documented as negative, a follow-up plan is not required <1% 4,613 $26K
83655 <1% 1,956 $19K
99382 <1% 157 $14K
99429 <1% 220 $7K
85018 <1% 4,028 $7K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 551 $7K
99384 <1% 54 $5K
87807 <1% 445 $5K
96160 <1% 3,515 $4K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 38 $3K
99203 Doctor's office visit, new patient (routine) <1% 53 $3K
90472 Immunization administration, each additional vaccine (list separately) <1% 344 $3K
99000 <1% 183 $2K
81002 <1% 562 $2K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 15 $656.06
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 36 $508.64
99080 <1% 13 $265.20
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 505 $20.88
97803 <1% 5,724 $15.50
94760 <1% 18 $3.92
90686 <1% 6,239 $2.92
90734 <1% 1,670 $0.55
90620 <1% 822 $0.52
97802 <1% 71 $0.24
90648 <1% 4,503 $0.22
90651 <1% 1,675 $0.19
90677 <1% 959 $0.18
90723 <1% 3,176 $0.18
90715 <1% 852 $0.18
90670 <1% 3,638 $0.12
90656 <1% 772 $0.08
90680 <1% 2,873 $0.07
90707 <1% 979 $0.04
90716 <1% 997 $0.02
90633 <1% 2,420 $0.02
90696 0% 1,101 $0.00
36416 0% 2,628 $0.00
90710 0% 1,252 $0.00
90700 0% 1,050 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMIRZA, MUHAMMAD (OWNER/PRESIDENT)